gene therapyGene therapy supplier MIP Discovery closes £7M Series A financingLatest NewsMIP Discovery Ltd has closed a £7M Series A financing to drive commercialisation of its synthetic affinity reagents in cell and gene therapy. Read more 20 February 2024 https://european-biotechnology.com/wp-content/uploads/2024/04/MIP.png 1134 1704 Thomas Gabrielczyk /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Thomas Gabrielczyk2024-02-20 10:13:482024-06-13 14:44:04Gene therapy supplier MIP Discovery closes £7M Series A financing